A large multicenter correlation study of thyroid nodule cytopathology and histopathology.

BACKGROUND Fine-needle aspiration (FNA) biopsies are the cornerstone of preoperative evaluation of thyroid nodules, but FNA diagnostic performance has varied across different studies. In the course of collecting thyroid FNA specimens for the development of a molecular diagnostic test, local cytology and both local and expert panel surgical pathology results were reviewed. METHODS Prospective FNAs were collected at 21 clinical sites. Banked FNAs were collected from two academic centers. Cytology and corresponding local and expert panel surgical pathology results were compared to each other and to a meta-review of 11 recently published U.S.-based thyroid FNA studies. RESULTS FNA diagnostic performance was comparable between the study specimens and the meta-review. Histopathology malignancy rates for prospective clinic FNAs were 34% for cytology indeterminate cases and 98% for cytology malignant cases, comparable to the figures found in the meta-review (34% and 97%, respectively). However, histopathology malignancy rates were higher for cytology benign cases in the prospective clinic FNA subcohort (11%) than in the meta-review (6%, with meta-review rates of 10% at community sites and 2% at academic centers, p < 0.0001). Resection rates for prospective clinic FNAs were also comparable to the meta-review for both cytology indeterminate cases (62% vs. 59%, respectively) and cytology malignant cases (82% vs. 81%, respectively). Surgical pathology categorical disagreement (benign vs. malignant diagnosis) was higher between local pathology and a consensus of the two expert panelists (11%) than between the two expert panelists both pre- (8%) and postconferral (3%). CONCLUSIONS Although recent guidelines for FNA biopsy and interpretation have been published, the rates of false-positive and false-negative results remain a challenge. Two-thirds of cytology indeterminate cases were benign postoperatively and may decrease with the development of an accurate molecular diagnostic test. High disagreement rates between local and expert panel histopathology diagnosis suggests that central review for surgical diagnoses should be used when developing diagnostic tests based on resected thyroid specimens.

[1]  Jeffrey E. Lee,et al.  Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. , 2003, American journal of surgery.

[2]  Amy Y. Chen,et al.  Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005 , 2009, Cancer.

[3]  Eric T. Wang,et al.  Molecular classification of thyroid nodules using high-dimensionality genomic data. , 2010, The Journal of clinical endocrinology and metabolism.

[4]  C. Lohse,et al.  Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma , 2004, The American journal of surgical pathology.

[5]  E. Mazzaferri,et al.  Fine Needle Aspiration Biopsy in the Management of Thyroid Nodules , 1991 .

[6]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[7]  D. Clark,et al.  A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. , 2008, Thyroid : official journal of the American Thyroid Association.

[8]  Martha Pitman,et al.  Thyroid fine-needle aspiration biopsy: variability in reporting. , 2009, Thyroid : official journal of the American Thyroid Association.

[9]  Jack Yang,et al.  Fine‐needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations , 2007, Cancer.

[10]  M. Hirokawa,et al.  Observer Variation of Encapsulated Follicular Lesions of the Thyroid Gland , 2002, The American journal of surgical pathology.

[11]  A. Miyauchi,et al.  An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients , 2009, World Journal of Surgery.

[12]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[13]  L. Thorne,et al.  Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. , 2008, Archives of otolaryngology--head & neck surgery.

[14]  D. Ross Predicting Thyroid Malignancy , 2006 .

[15]  M. Sack,et al.  Recent experience with preoperative fine-needle aspiration biopsy of thyroid nodules in a community hospital. , 2002, Archives of surgery.

[16]  Z. Baloch,et al.  Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology , 2002, Diagnostic cytopathology.

[17]  J. Netterville,et al.  Implications of Follicular Neoplasms, Atypia, and Lesions Suspicious for Malignancy Diagnosed by Fine-Needle Aspiration of Thyroid Nodules , 2002, Annals of surgery.

[18]  Z. Baloch,et al.  Fine‐needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow‐up according to National Cancer Institute (NCI) recommendations , 2010, Diagnostic cytopathology.

[19]  Howard H. Wu,et al.  Fine‐needle aspiration cytology of the thyroid: Ten years experience in a community teaching hospital , 2006, Diagnostic cytopathology.

[20]  R. Nayar,et al.  The indeterminate thyroid fine‐needle aspiration , 2009, Cancer.

[21]  A. Berner,et al.  Fine‐needle aspiration cytology of the thyroid gland: Comparative analysis of experience at three hospitals , 2006, Diagnostic cytopathology.

[22]  S. Devesa,et al.  Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[23]  D. Ross Editorial: predicting thyroid malignancy. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  A. Gawande,et al.  Long‐term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation , 2007, Cancer.

[25]  O. Clark,et al.  False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.

[26]  Shuangge Ma,et al.  A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. , 2009, Thyroid : official journal of the American Thyroid Association.

[27]  J. Rosai,et al.  Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors , 2000, International journal of surgical pathology.

[28]  A. Pinchera,et al.  Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. , 2010, The Journal of clinical endocrinology and metabolism.

[29]  J. Fleiss Statistical methods for rates and proportions , 1974 .

[30]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[31]  E. Mazzaferri,et al.  Management of a solitary thyroid nodule. , 1993, The New England journal of medicine.

[32]  T. Fahey Value of Repeated Fine Needle Aspirations of the Thyroid: An Analysis of Over Ten Thousand FNAs , 2008 .

[33]  R. Udelsman,et al.  The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. , 2009, Thyroid : official journal of the American Thyroid Association.

[34]  B. Franc Observer variation of lesions of the thyroid. , 2003, The American journal of surgical pathology.

[35]  Juan Rosai,et al.  Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference , 2008, Diagnostic cytopathology.

[36]  H. Gharib,et al.  Continuing Controversies in the Management of Thyroid Nodules , 2005, Annals of Internal Medicine.

[37]  M. P. Martegani,et al.  Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. , 2008, The Lancet. Oncology.